Search

Search Constraints

You searched for: Author/Creator Muñoz-Couselo, Eva

Search Results

1. A slow-cycling LGR5 tumour population mediates basal cell carcinoma relapse after therapy. (18th October 2018)

2. Adjuvant Therapy of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Patients With Resected Stage IIIB-D or Stage IV Melanoma (CheckMate 915). Issue 3 (26th September 2022)

3. BRAF mutation analysis in circulating free tumor DNA of melanoma patients treated with BRAF inhibitors. Issue 6 (December 2015)

4. Cancer immunotherapy in special challenging populations: recommendations of the Advisory Committee of Spanish Melanoma Group (GEM). Issue 3 (29th March 2021)

5. Cancer immunotherapy in special challenging populations: recommendations of the Advisory Committee of Spanish Melanoma Group (GEM). Issue 3 (29th March 2021)

7. Efficacy and safety of immune checkpoint inhibitors in young adults with metastatic melanoma. (March 2023)

8. Immune analysis of lymph nodes in relation to the presence or absence of tumor infiltrating lymphocytes in triple-negative breast cancer. (May 2021)

10. Pembrolizumab versus investigator-choice chemotherapy for metastatic triple-negative breast cancer (KEYNOTE-119): a randomised, open-label, phase 3 trial. Issue 4 (April 2021)